|
|
Article: Schering-Plough Chairman/CEO Fred Hassan Reviews Progress in Action Agenda at Annual Shareholders Meeting.
- Article from:
- PR Newswire
- Article date:
- April 26, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PALO ALTO, Calif., April 26 /PRNewswire-FirstCall/ -- Addressing shareholders at today's Annual Meeting of Schering-Plough Corporation , Fred Hassan, chairman and chief executive officer, recounted the challenges on many fronts that faced the company for the past two years and reviewed the progress being achieved in the Action Agenda to build the New Schering-Plough.
"We have confronted some enormous challenges over the past couple of years," said Hassan. "Now we are engaged in a new stage of our work. On the solid foundations that we are setting, we are building a new kind of health care company, one that will be uniquely equipped to deliver high performance ...
Related newspaper, magazine, and journal articles:
|
|
Article: Drugmaker readies son of Claritin; New ...
Advertising Age;
August 7, 2000 ;
700+ words
...Schering-Plough's Corp.'s so-called son of Claritin will resemble its predecessor quite a bit. Schering-Plough hopes to dub the blockbuster allergy drug's successor Clarinex, according to people familiar with the matter. Schering-Plough is awaiting approval from the U.S. Food & Drug
|
|